These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 24059332)

  • 21. Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein.
    Xie Z; O'Rourke KI; Dong Z; Jenny AL; Langenberg JA; Belay ED; Schonberger LB; Petersen RB; Zou W; Kong Q; Gambetti P; Chen SG
    J Biol Chem; 2006 Feb; 281(7):4199-206. PubMed ID: 16338930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular biology and pathogenesis of prion diseases.
    Prusiner SB
    Trends Biochem Sci; 1996 Dec; 21(12):482-7. PubMed ID: 9009832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A survey and a molecular dynamics study on the (central) hydrophobic region of prion proteins.
    Zhang J; Wang F
    Curr Pharm Biotechnol; 2014; 15(11):1026-48. PubMed ID: 25373387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prion diseases and emerging prion diseases.
    Yokoyama T; Mohri S
    Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy.
    Vana K; Zuber C; Nikles D; Weiss S
    Cell Mol Neurobiol; 2007 Feb; 27(1):107-28. PubMed ID: 17151946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein self-interaction in prion disease therapy approaches.
    Rigter A; Priem J; Langeveld JP; Bossers A
    Vet Q; 2011 Sep; 31(3):115-28. PubMed ID: 22029882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transmission of spongiform encephalopathies (prion diseases)].
    Federspil P; Federspil PA
    HNO; 2002 Apr; 50(4):316-26. PubMed ID: 12063689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.
    Caramelli M; Ru G; Acutis P; Forloni G
    CNS Drugs; 2006; 20(1):15-28. PubMed ID: 16396521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability properties of PrP(Sc) from cattle with experimental transmissible spongiform encephalopathies: use of a rapid whole homogenate, protease-free assay.
    Vrentas CE; Greenlee JJ; Baron T; Caramelli M; Czub S; Nicholson EM
    BMC Vet Res; 2013 Aug; 9():167. PubMed ID: 23945217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acquired human prion diseases--past and present issues].
    Hagiwara K; Yamakawa Y; Hanada K
    Uirusu; 2009 Dec; 59(2):155-65. PubMed ID: 20218324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
    Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
    OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
    Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
    Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A trend of molecular genetics on prion diseases and prion protein].
    Muramatsu Y; Shinagawa M
    Nihon Rinsho; 1993 Sep; 51(9):2494-502. PubMed ID: 8411733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PrP knock-out and PrP transgenic mice in prion research.
    Weissmann C; Flechsig E
    Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Accumulation of Misfolded Prion Strains in Natural Hosts of Prion Diseases.
    Lambert ZJ; Greenlee JJ; Cassmann ED; West Greenlee MH
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.